Valuation: Elekta AB (publ)

Market Cap 18.49B 1.94B 1.68B 1.57B 1.44B 2.72B 185B 2.76B 7.25B 92.11B 7.28B 7.12B 309B P/E 2027 *
12.9x
P/E 2028 * 11.5x
Enterprise Value 21.95B 2.3B 2B 1.86B 1.71B 3.23B 220B 3.28B 8.62B 109B 8.64B 8.45B 367B EV / Sales 2027 *
1.27x
EV / Sales 2028 * 1.19x
Free-Float
94.03%
Yield 2027 *
5.18%
Yield 2028 * 5.71%

Last Transcript: Elekta AB (publ)

Manager TitleAgeSince
Chief Executive Officer - 01/09/2025
Director of Finance/CFO - 01/03/2026
Investor Relations Contact - 01/12/2023
Director TitleAgeSince
Director/Board Member 69 30/06/2010
Director/Board Member 70 15/09/2011
Chairman 74 03/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+1.08%-0.08% - - 1.94B
-0.43%+1.06%+22.80%+4.67% 213B
-0.61%+1.82%-1.11%-23.56% 137B
+0.10%+4.69%-26.56%+8.92% 125B
+1.59%+5.60%-55.46%-9.87% 69.46B
-0.98%+4.16%+8.52%+4.87% 49.56B
-0.91%+5.13%-22.07%-30.22% 47.2B
-0.25%-0.14%+20.52%+13.63% 39.08B
-0.79%+0.70%+30.67%+36.60% 37.05B
-2.75%+12.28%-4.63%-12.79% 30.72B
Average -0.39%+3.87%-3.03%-0.86% 83.15B
Weighted average by Cap. -0.35%+3.04%-1.71%-1.99%

Financials

2027 *2028 *
Net sales 17.31B 1.82B 1.58B 1.47B 1.35B 2.55B 173B 2.59B 6.79B 86.27B 6.82B 6.67B 289B 18.06B 1.89B 1.65B 1.53B 1.41B 2.66B 181B 2.7B 7.09B 89.98B 7.11B 6.95B 302B
Net income 1.43B 150M 130M 121M 111M 210M 14.31B 214M 561M 7.12B 563M 551M 23.89B 1.61B 168M 146M 136M 125M 236M 16.08B 240M 631M 8.01B 633M 619M 26.85B
Net Debt 3.47B 364M 316M 294M 270M 510M 34.72B 518M 1.36B 17.28B 1.37B 1.34B 57.96B 3B 315M 274M 255M 234M 442M 30.04B 448M 1.18B 14.96B 1.18B 1.16B 50.16B
Logo Elekta AB (publ)
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-